Identity
- Trade Name
- GORE VIABIL Biliary Endoprosthesis FDA UDI
- Generic Name
- Polymer-metal biliary stent, non-bioabsorbable FDA UDI
- Device Name
- GORE VIABIL BILIARY ENDO 8mmX10cm 10Fr FDA UDI
- Model / Reference
- VN0810040 FDA UDI
- Description
- GORE VIABIL BILIARY ENDO 8mmX10cm 10Fr FDA UDI
Identifiers
- Catalog Number
- VN0810040 FDA UDI
- Primary DI / UDI-DI
- 00733132615650 FDA UDI
- FDA Product Code
- FGE FDA UDI
- GMDN Term
- Polymer-metal biliary stent, non-bioabsorbable FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 876.5010 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Conditional FDA UDI
Dimensions & Sizes
- Size
- Catheter Gauge — 10 French FDA UDILength — 10 Centimeter FDA UDILumen/Inner Diameter — 8 Millimeter FDA UDI
Category: Polymer-metal biliary stent, non-bioabsorbable
GORE VIABIL Biliary Endoprosthesis by W. L. Gore & Associates, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Polymer-metal biliary stent, non-bioabsorbable.
- WallFlex™ Biliary Transhepatic — Boston Scientific · Class II
- WallFlex™ — Boston Scientific · Class II
- WallFlex™ Biliary Transhepatic — Boston Scientific · Class II
- WallFlex™ Biliary — Boston Scientific · Class II
- WallFlex™ — Boston Scientific · Class II
- WallFlex™ — Boston Scientific · Class II
- WallFlex Biliary — Boston Scientific · Class II
- WALLSTENT™ RX BILIARY — Boston Scientific · Class II
Cleared under the same submission
K041423 also covers:
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
K081184 also covers:
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
- GORE VIABIL Biliary Endoprosthesis — W. L. GORE & ASSOCIATES, INC
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- W. L. Gore & Associates, Inc
Sources (1)
- FDA UDI ece8e5ee-3afb-49d0-b580-d4e447e2688b 37 fields · synced Jun 1, 2026